CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

KRAS any mutation — panitumumab resistance

Gene: KRAS · Type: mutation

Indications: Colorectal cancer

SensitivityResistanceCIViC Context

FDA Resistance Assertions

DrugIndicationRecommendationFDA SourceLink
PanitumumabColorectal cancerCONTRAINDICATED
FDA Label
Label